Ables Iannone Moore & Associates’s Amgen AMGN Stock Holding History

Ables Iannone Moore & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Hold	2,858	–	–	0.55%	33
2026 Q1	$1.01M	Sell	2,858 -275	-9%	-$98K	0.6%	34
2025 Q4	$1.03M	Sell	3,133 -101	-3%	-$32K	0.56%	34
2025 Q3	$913K	Sell	3,234 -110	-3%	-$31.9K	0.52%	34
2025 Q2	$934K	Sell	3,344 -16	-0.5%	-$4.53K	0.58%	35
2025 Q1	$1.05M	Sell	3,360 -5	-0.1%	-$1.48K	0.71%	30
2024 Q4	$877K	Buy	3,365 +1	+0%	+$297	0.54%	34
2024 Q3	$1.08M	Hold	3,364	–	–	0.7%	30
2024 Q2	$1.05M	Sell	3,364 -31	-0.9%	-$9.11K	0.7%	30
2024 Q1	$965K	Hold	3,395	–	–	0.69%	31
2023 Q4	$978K	Buy	+3,395	New	+$925K	0.75%	28

Other funds holding AMGN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Ables Iannone Moore & Associates's AMGN Position: Q2 2026 in Review

Ables Iannone Moore & Associates held its Amgen (AMGN) position steady in Q2 2026 at 2,858 shares worth $1.04M. The position accounts for 0.55% of the portfolio, ranked #33.

Ables Iannone Moore & Associates first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.08M in Q3 2024. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Ables Iannone Moore & Associates held 2,858 shares of Amgen worth $1.04M as of Q2 2026.
Ables Iannone Moore & Associates left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.55% of Ables Iannone Moore & Associates's portfolio in Q2 2026, its #33 holding.
Ables Iannone Moore & Associates first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
Ables Iannone Moore & Associates's Amgen position peaked at $1.08M in Q3 2024.
659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ables Iannone Moore & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.